Why Neumora Therapeutics (NMRA) Faces a Major Catalyst From Navacaprant’s Upcoming Depression Data

This is a summary. Read the complete story at Yahoo Finance below.

Related Stories

marketsabout 2 hours ago

Rumble gets 22,000 Nvidia chips, but the video company’s CEO insists this isn’t a fad-like pivot

Is Rumble’s AI expansion just Allbirds 2.0 — or a move modeled after Elon Musk?

MarketWatch

marketsabout 2 hours ago

Did Warsh and Vance just open the door to higher inflation?

The U.S. government’s official 2% annual inflation target has suddenly been thrown into doubt by Kevin Warsh and J.D. Vance.

MarketWatch

marketsabout 2 hours ago

Warren Buffett’s mentor said his wealth came down to luck. Is your life savings riding on a coin flip?

The illusion of investing knowledge is powerful: Why you’re probably paying a financial adviser for pure chance.

MarketWatch